Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2066539 | Toxicon | 2008 | 7 Pages |
Abstract
RGD-peptides can inhibit the binding of ligands to certain β3 integrins, αIIbβ3 and αvβ3, both of which are involved in neointimal hyperplasia that contributes to atherosclerosis and restenosis of arterial walls. Saxatilin, a disintegrin from a Korean snake (Gloydius saxatilis), interacts with integrins αIIbβ3 and αvβ3. It suppressed the adhesion of human coronary artery smooth muscle cells (HCASMCs) to vitronectin with an IC50 of 2.5 μM, and growth factor (PDGF-BB or bFGF)-induced proliferation was inhibited at an IC50 of 25 μM. Saxatilin disassembled the actin cytoskeleton of focal adhesion and induced cell detachment. This disassembly of focal adhesion in saxatilin-treated HCASMCs involved caspase-induced paxillin degradation. Saxatilin temporally phosphorylated FAK and ERKs and affected the cell cycle of HCASMCs by increasing CDK inhibitors (p21 and p27) and reducing cyclins (D1/2 and E). These results may have significant implications for integrin antagonistic therapy used for the treatment of atherosclerosis and restenosis.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry, Genetics and Molecular Biology (General)
Authors
Young-Doug Sohn, Kil-Sang Cho, Sae-Ah Sun, Hee-Jin Sung, Kyu-Won Kwak, Sung-Yu Hong, Doo-Sik Kim, Kwang-Hoe Chung,